Roivant Sciences Insider Trades: Executives Buy, Sell, and Exercise 40K Shares Under SEC‑Approved Plan
Roivant Sciences’ latest insider trade report reveals a senior executive’s strategic buy‑sell‑option activity, balancing liquidity and long‑term equity while fully complying with SEC Rule 10(b)(5) and boosting investor confidence.
3 minutes to read